Box-Behnken modeling was used to optimize a resinate complex, to mask the taste of levocetirizine dihydrochloride and montelukast sodium in orally disintegrating tablets.
Box-Behnken modeling was used to optimize a resinate complex, to mask the taste of levocetirizine dihydrochloride and montelukast sodium in orally disintegrating tablets.
If FDA’s proposed generic-drug labeling rule is passed in 2017, generic drug companies would need documented processes for safety tracking and label updates.
Most countries are not prepared to respond to infectious disease outbreaks -Military and scientific efforts provide valuable insights for response plans -Lt. Col. Mesngon discusses his role in global health engagement in Uganda
The Nexera UC combines possible UHPLC and SFC separation in a single system. Depending on the focused application, it can offer “green” separation but also more speed and separation power.
The Agilent 280-DS Mechanical Qualification System (MQS) simplifies dissolution qualification. The system that has taken the dissolution industry by storm now has even more capabilities.
Welcome to Pharmaceutical Technology’s Drug Development Application Handbook, a compilation of technical articles from the magazine’s archives and application notes, technical information, and educational materials from the handbook’s sponsors. In this ebook, you will find insight and guidance on quality risk management, highly potent APIs, quality by design for API development, aseptic processing, tablet manufacturing, equipment, and more. We hope this information is useful in supporting your drug development and manufacturing operations.
This article discusses cleaning validation of equipment dedicated to the production of a single API.
This article discusses cleaning validation of equipment dedicated to the production of a single API.
This article discusses cleaning validation of equipment dedicated to the production of a single API.
This article discusses cleaning validation of equipment dedicated to the production of a single API.
This article discusses cleaning validation of equipment dedicated to the production of a single API.
This article discusses cleaning validation of equipment dedicated to the production of a single API.
This article discusses cleaning validation of equipment dedicated to the production of a single API.
This article discusses cleaning validation of equipment dedicated to the production of a single API.
Heightened regulatory scrutiny of data integrity highlights the need for comprehensive procedural reviews and strategies for managing mission-critical information.
Heightened regulatory scrutiny of data integrity highlights the need for comprehensive procedural reviews and strategies for managing mission-critical information.
Heightened regulatory scrutiny of data integrity highlights the need for comprehensive procedural reviews and strategies for managing mission-critical information.
How real estate can accelerate productivity as life sciences companies prioritize COVID-19 therapeutics, vaccines, and new diagnostics R&D amidst new guidelines.
Delivery systems that allow drugs to be administered as liquids, but to form gel within the eye, promise to improve efficacy and patient compliance.
Delivery systems that allow drugs to be administered as liquids, but to form gel within the eye, promise to improve efficacy and patient compliance.
Delivery systems that allow drugs to be administered as liquids, but to form gel within the eye, promise to improve efficacy and patient compliance.
Engineered containment performance testing is a more robust method for validating containment systems than worker-exposure measurement methods.
Engineered containment performance testing is a more robust method for validating containment systems than worker-exposure measurement methods.
The relatively low success rates for bio/pharmaceutical compounds in clinical development have prompted many organizations to explore ways of reducing risk in clinical development.
As more patents make their way through IPRs, the balance of how the pharmaceutical industry selects between IPRs and district court litigation will likely evolve.
Susan Schniepp, distinguished fellow, and Andrew Harrison, chief regulatory affairs officer and general counsel, both of Regulatory Compliance Associates, discuss requirements for successful product technology transfer.